| 1 |
Copete AR, Vera C, Herrera M, et al. Mycoplasma pneumoniae in children with and without community-acquired pneumonia. What do PCR and serology say[J]. Pediatr Infect Dis J, 2020, 39(7): e104-e108.
|
| 2 |
殷 荣，张 涛，戴 鸽，等. 711例流感病毒肺炎患儿临床特点及重症危险因素分析[J]. 国际儿科学杂志，2022, 49(2): 135-139.
|
| 3 |
Gao J, Xu L, Xu B, et al. Human adenovirus coinfection aggravates the severity of Mycoplasma pneumoniae pneumonia in children[J]. BMC Infect Dis, 2020, 20(1): 420.
|
| 4 |
蒋星华，周良芳，邓 剑，等. 儿童肺炎支原体感染920例临床分析[J]. 中南医学科学杂志，2019, 47(2): 195-197.
|
| 5 |
Krafft C, Christy C. Mycoplasma pneumonia in children and adolescents[J]. Pediatr Rev, 2020, 41(1): 12-19.
|
| 6 |
Kutty PK, Jain S, Taylor TH, et al. Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia[J]. Clin Infect Dis, 2019, 68(1): 5-12.
|
| 7 |
Jin HL, Zhan L, Mei SF, et al. Serum cytokines and FeNO in school-aged children with Mycoplasma pneumoniae pneumonia[J]. Med Sci Monit, 2020, 21(26): 923449.
|
| 8 |
Lee YC, Chang CH, Lee WJ, et al. Altered chemokine profile in Refractory Mycoplasma pneumoniae pneumonia infected children[J]. J Microbiol Immunol Infect, 2021, 54(4): 673-679.
|
| 9 |
《诸福棠实用儿科学》第8版书讯[J]. 临床儿科杂志，2015, (4): 308-308.
|
| 10 |
Li Y, Guo Z, Zhang G, et al. The correlation between vitamin a status and refractory Mycoplasma Pneumoniae pneumonia (RMPP) incidence in children[J]. BMC Pediatr, 2020, 20(1): 359.
|
| 11 |
Meyer Sauteur PM, Berger C. Proadrenomedullin in Mycoplasma pneumoniae community-acquired pneumonia in children[J]. Clin Infect Dis, 2021, 73(7): 1769-1771.
|
| 12 |
Shah SS. Mycoplasma pneumoniae as a cause of community-acquired pneumonia in children[J]. Clin Infect Dis, 2019, 68(1): 13-14.
|
| 13 |
Gayam V, Konala VM, Naramala S, et al. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA[J]. J Med Virol, 2020, 92(10): 2181-2187.
|
| 14 |
江 琰，王 华，方 琴，等. 肺炎支原体肺炎早期糖皮质激素治疗对肺功能的影响[J]. 中南医学科学杂志，2019, 47(6): 658-660.
|
| 15 |
杨会荣，刘建华，赵秀敏，等. 清热解毒方对支原体肺炎患儿肺泡灌洗液中支原体病菌量的影响[J]. 河北中医药学报，2018, 33(3): 21-23.
|
| 16 |
杜 莉，陈 亮，卓 越，等. PCT、sTREM-1、SPA和sICAM-1在支原体肺炎患儿中的检测价值[J]. 国际检验医学杂志，2020, 41(3): 368-371.
|
| 17 |
张开明. 支原体肺炎通过肺功能检测患哮喘概率[J]. 中国保健营养，2019, 29(26): 282.
|
| 18 |
Liu J, He R, Wu R, et al. Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children′s hospital[J]. BMC Infect Dis, 2020, 20(1): 51-55.
|
| 19 |
Varghese SM, Kerkar VV. Macrolide resistant Mycoplasma pneumoniae in community acquired pneumonia[J]. Indian J Pediatr, 2020, 87(11): 958-962.
|
| 20 |
郑敏斯，何德根，高 梅. 肺炎支原体感染对支气管哮喘患儿FeNO及肺功能指标的影响[J]. 黑龙江医药，2018, 31(3): 497-499.
|
| 21 |
胡必梅，江桂林，梁祥祥，等. 下呼吸道肺炎支原体感染对患儿肺功能与血清NO水平及Th1/Th2平衡的影响研究[J]. 中华医院感染学杂志，2020, 30(10): 1559-1563.
|
| 22 |
吴跃进，孙 节，范典标，等. 肺炎支原体肺炎患儿呼出气一氧化氮水平变化及其临床意义[J]. 中国基层医药，2018, 25(24): 3171-3174.
|
| 23 |
吕明珠，陈全景，庞永琴. 支气管哮喘患儿外周血黏膜相关恒定T细胞表达及与病情的相关性[J]. 中国医师进修杂志，2020, 43(2): 167-171.
|
| 24 |
李 静，刘长山，王雪艳，等. 儿童肺炎支原体肺炎肺功能改变及临床意义的探讨[J]. 天津医科大学学报，2018, 24(3): 229-231.
|
| 25 |
冯 静，李 姗，王 娜，等. 头孢哌酮钠舒巴坦钠对社区获得性肺炎患者FeNO水平及炎性细胞因子的影响[J]. 中国合理用药探索，2019, 16(5): 165-167, 171.
|